Risk Stratification, Prevention Guidelines, Cholesterol Management Heart Failure, and Cardiovascular-Kidney-Metabolic Syndrom

Course overview

1. Apply risk stratification tools to estimate 10 and 30 year risk of CV events. 2. Review guidelines for primary prevention of CV disease. 3. Determine optimal LDL-C levels for patients with secondary prevention. 4. Develop evidence based approach for use of statin and non-statin therapies to address CV risk. 5. Review guidelines for diagnosis and management of heart failure with reduced ejection fraction. 6. Understand the role of quadruple therapy in management of HFrEF. 7. Apply validated tools to improve the diagnosis of HFpEF. 8. Use evidence based therapies to improve outcomes in HFpEF. 9. Review the framework on Cardiovascular-Kidney-Metabolic Syndrome. 10. Apply cardio-reno-metabolic therapies to improve outcomes for patients with CKM syndrome Presentations: Evidence based LDL-Cholesterol Management Beyond LDL - Optimal management of hyperlipidemia Updates in Heart Failure (HFrEF) Updated in Heart Failure (HFpEF) Identifying and Managing the Cardiovascular-Kidney-Metabolic Syndrome